Patent · US Active

IL-2Rγ binding compounds

US10689417B2 · kind B2 · utility

8Cited by
2References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2019
Grant dateJun 23, 2020
Priority date
Expiry dateAug 5, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

IL-2Rβ ligands and IL-2Rγc ligands and compounds comprising the ligands are disclosed. The ligands and compounds such as heterodimers and fusion proteins comprising the IL-2Rβ ligands and/or the IL-2Rγc ligands can be IL-2 receptor agonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.